Clinical, Cosmetic and Investigational Dermatology (Dec 2018)

Botulinum neurotoxin formulations: overcoming the confusion [Corrigendum]

  • Samizadeh S,
  • De Boulle K

Journal volume & issue
Vol. Volume 11
pp. 629 – 630

Abstract

Read online

Samizadeh S, De Boulle K. Clin Cosmet Investig Dermatol. 2018;11:273–287.On page 273, Introduction section, line 5, the sentence “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and unaffected by D.1,4–6” should be changed to “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and almost unaffected by D.1,4–6,131”. On page 273, Introduction section, line 11, “BoNTs” should be changed to “botulinum toxins”. On page 276, Table 2, Storage conditions column, “Below 8°C” should be changed to “2°C–8°C”.  Read the original article